These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 3138240

  • 41. Aspirin induces alterations in low-density lipoprotein and decreases its catabolism by cultured human fibroblasts.
    Mazière C, Goldstein S, Moreau M, Mazière JC, Polonovski J.
    FEBS Lett; 1987 Jun 29; 218(2):243-6. PubMed ID: 3036591
    [Abstract] [Full Text] [Related]

  • 42. Genetic evidence that the putative receptor binding domain of apolipoprotein B (residues 3130 to 3630) is not the only region of the protein involved in interaction with the low density lipoprotein receptor.
    Dunning AM, Houlston R, Frostegård J, Revill J, Nilsson J, Hamsten A, Talmud P, Humphries S.
    Biochim Biophys Acta; 1991 Apr 15; 1096(3):231-7. PubMed ID: 2018797
    [Abstract] [Full Text] [Related]

  • 43. The use of monoclonal antibodies to localize the low density lipoprotein receptor-binding domain of apolipoprotein B.
    Milne R, Théolis R, Maurice R, Pease RJ, Weech PK, Rassart E, Fruchart JC, Scott J, Marcel YL.
    J Biol Chem; 1989 Nov 25; 264(33):19754-60. PubMed ID: 2479639
    [Abstract] [Full Text] [Related]

  • 44. Solubilization of apolipoprotein B and its specific binding by the cellular receptor for low density lipoprotein.
    Shireman R, Kilgore LL, Fisher WR.
    Proc Natl Acad Sci U S A; 1977 Nov 25; 74(11):5150-4. PubMed ID: 200946
    [Abstract] [Full Text] [Related]

  • 45. Oxidation of low density lipoprotein particles decreases their ability to bind to human aortic proteoglycans. Dependence on oxidative modification of the lysine residues.
    Oörni K, Pentikäinen MO, Annila A, Kovanen PT.
    J Biol Chem; 1997 Aug 22; 272(34):21303-11. PubMed ID: 9261142
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Proposed mechanisms for binding of apo[a] kringle type 9 to apo B-100 in human lipoprotein[a].
    Guevara J, Spurlino J, Jan AY, Yang CY, Tulinsky A, Prasad BV, Gaubatz JW, Morrisett JD.
    Biophys J; 1993 Mar 22; 64(3):686-700. PubMed ID: 8386013
    [Abstract] [Full Text] [Related]

  • 48. Plasma triglycerides determine low density lipoprotein composition, physical properties, and cell-specific binding in cultured cells.
    McKeone BJ, Patsch JR, Pownall HJ.
    J Clin Invest; 1993 May 22; 91(5):1926-33. PubMed ID: 8387537
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. The receptor binding domain of apolipoprotein E, linked to a model class A amphipathic helix, enhances internalization and degradation of LDL by fibroblasts.
    Datta G, Chaddha M, Garber DW, Chung BH, Tytler EM, Dashti N, Bradley WA, Gianturco SH, Anantharamaiah GM.
    Biochemistry; 2000 Jan 11; 39(1):213-20. PubMed ID: 10625496
    [Abstract] [Full Text] [Related]

  • 51. In vitro proteolysis of human plasma low density lipoproteins by an elastase released from human blood polymorphonuclear cells.
    Polacek D, Byrne RE, Fless GM, Scanu AM.
    J Biol Chem; 1986 Feb 15; 261(5):2057-63. PubMed ID: 3632977
    [Abstract] [Full Text] [Related]

  • 52. Estrogen increases low-density lipoprotein receptor-independent catabolism of apolipoprotein B in hyperlipidemic rabbits.
    Colvin PL.
    Metabolism; 1996 Jul 15; 45(7):889-96. PubMed ID: 8692027
    [Abstract] [Full Text] [Related]

  • 53. Characterization of high density lipoprotein binding to human adipocyte plasma membranes.
    Fong BS, Rodrigues PO, Salter AM, Yip BP, Despres JP, Angel A, Gregg RE.
    J Clin Invest; 1985 Jun 15; 75(6):1804-12. PubMed ID: 2989332
    [Abstract] [Full Text] [Related]

  • 54. Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts.
    Weisgraber KH, Innerarity TL, Mahley RW.
    J Biol Chem; 1978 Dec 25; 253(24):9053-62. PubMed ID: 214439
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E.
    Clavey V, Lestavel-Delattre S, Copin C, Bard JM, Fruchart JC.
    Arterioscler Thromb Vasc Biol; 1995 Jul 25; 15(7):963-71. PubMed ID: 7600129
    [Abstract] [Full Text] [Related]

  • 57. Monoclonal antibody 5A binds apolipoprotein B-48 and inhibits the low density lipoprotein-receptor interaction.
    Corsini A, Fantappiè S, Marcovina S, Granata A, Fumagalli R, Catapano AL.
    Biochem Biophys Res Commun; 1989 Aug 15; 162(3):908-15. PubMed ID: 2475112
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Binding of plasma low density lipoproteins to erythrocytes.
    Hui DY, Noel JG, Harmony JA.
    Biochim Biophys Acta; 1981 Jun 23; 664(3):513-26. PubMed ID: 6791697
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.